Harbor Capital Advisors’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.75M Sell
17,293
-16
-0.1% -$1.66K 0.12% 248
2026
Q1
$1.67M Buy
17,309
+5,236
+43% +$537K 0.14% 228
2025
Q4
$1.28M Sell
12,073
-2
-0% -$232 0.1% 281
2025
Q3
$1.53M Sell
12,075
-39,062
-76% -$4.65M 0.12% 229
2025
Q2
$6.27M Sell
51,137
-17,027
-25% -$1.94M 0.26% 123
2025
Q1
$6.9M Sell
68,164
-4,463
-6% -$436K 0.31% 108
2024
Q4
$6.71M Sell
72,627
-645
-0.9% -$63.3K 0.29% 104
2024
Q3
$7.08M Buy
73,272
+37,473
+105% +$3.37M 0.31% 94
2024
Q2
$3.07M Buy
35,799
+26,270
+276% +$2.2M 0.23% 122
2024
Q1
$787K Buy
+9,529
New +$698K 0.1% 271
2023
Q3
Sell
-1,534
Closed -$104K 505
2023
Q2
$104K Buy
+1,534
New +$96.1K 0.02% 429

Other funds holding EHC

Harbor Capital Advisors's EHC Position: Q2 2026 in Review

Harbor Capital Advisors reduced its Encompass Health (EHC) stake by 0.09% in Q2 2026, selling an estimated $1.66K and leaving 17,293 shares worth $1.75M. The position accounts for 0.12% of the portfolio, ranked #248.

Harbor Capital Advisors first reported a position in EHC in Q2 2023 and has held it in 11 quarters since. The position peaked at $7.08M in Q3 2024. 339 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Harbor Capital Advisors held 17,293 shares of Encompass Health worth $1.75M as of Q2 2026.
  • Harbor Capital Advisors sold 16 Encompass Health shares in Q2 2026, an estimated $1.66K.
  • Encompass Health made up 0.12% of Harbor Capital Advisors's portfolio in Q2 2026, its #248 holding.
  • Harbor Capital Advisors first reported a position in Encompass Health in Q2 2023 and has held it in 11 quarters since.
  • Harbor Capital Advisors's Encompass Health position peaked at $7.08M in Q3 2024.
  • 339 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Harbor Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.